|
Index of reports
> Cases with Flushing (52)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include flushing. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 52 Next >>
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Flushing, Fatigue, Diarrhoea, Pain in Extremity, Pain, Dizziness, Muscle Spasms
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2012-07-04
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2012-07-04
Sandostatin
Dosage: every 12 hrs
Start date: 2012-08-14
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Dyspnoea, Disorientation, Discomfort, Blood Glucose Decreased, Abdominal Discomfort, Flushing, Diarrhoea, Blood Glucose Fluctuation, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Sandostatin LAR
Dosage: 20 mg, (every 2 weeks)
Other drugs received by patient: Lantus; Novorapid
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-03
Patient: male
Reactions: Abdominal Pain, Nasopharyngitis, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Diarrhoea, Gastrointestinal Neoplasm, Neoplasm Malignant, Dysphonia, Arthralgia, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine Sulfate
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-07-31
Patient: male
Reactions: Flushing, Abdominal Discomfort, Dyspnoea, Diarrhoea, Blood Glucose Fluctuation, Disorientation, Feeling Abnormal, Discomfort
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Other drugs received by patient: Novorapid; Lantus
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-07-25
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Confusional State, Weight Decreased, Incorrect Route of Drug Administration, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Discomfort, Injection Site Erythema, Malaise, Fatigue, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, tid prn
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-06-22
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Cardiac Murmur, Blood Urine Present, Pain in Extremity, Hypoaesthesia, Tremor, Carcinoid Tumour of THE Pancreas, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Dyspnoea, Vomiting, Nausea, Retching, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Hypertension, Blood Pressure Fluctuation, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Lyrica; Codeine; Lantus; Rasilez D; Ranitidine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-19
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Blood Urine Present, Cardiac Murmur, Pain in Extremity, Hypoaesthesia, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Vomiting, Dyspnoea, Retching, Nausea, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Asthenia, Blood Pressure Fluctuation, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Other drugs received by patient: Propranolol; Lyrica; Lantus; Rasilez D; Codeine; Ranitidine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-06-06
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Erythema, Fatigue, Injection Site Discomfort, Malaise, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Blood Pressure Systolic Increased, Pain in Extremity, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-05
Patient: male
Reactions: Flushing, Abdominal Discomfort, Diarrhoea, Blood Glucose Fluctuation, Disorientation, Feeling Abnormal, Discomfort
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Other drugs received by patient: Novorapid; Lantus
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-06-01
Patient: male
Reactions: Death, Flushing, Diarrhoea, Abdominal Distension
Adverse event resulted in: death
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-21
Sandostatin
Dosage: 100 ug, q8h
Indication: Metastatic Carcinoid Tumour
Start date: 2011-05-18
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-06-01
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Neoplasm Malignant, Dysphonia, Gastrointestinal Neoplasm, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-28
Patient: male
Reactions: Flushing, Diarrhoea, Disorientation, Blood Glucose Fluctuation, Feeling Abnormal, Discomfort
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Sandostatin
Indication: Carcinoid Syndrome
Other drugs received by patient: Novorapid; Lantus
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-28
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Confusional State, Weight Decreased, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Fatigue, Injection Site Discomfort, Injection Site Erythema, Malaise, Hot Flush, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 0.75 ml, bid
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-05-25
Patient: male
Reactions: Abdominal Pain, Headache, Fall, Erythema, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Oedema Peripheral, Dizziness, Heart Rate Irregular, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Blood Urine Present, Vomiting, Chest Discomfort, Dyspnoea, Cardiac Murmur, Pain in Extremity, Nausea, Retching, Lung Neoplasm, Hypoaesthesia, Burning Sensation, Flushing, Heart Rate Decreased, Diarrhoea, Heart Rate Increased, Vision Blurred, Hypertension, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Codeine Sulfate; Lantus; Rasilez D; Lyrica; Ranitidine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-18
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Injection Site Haematoma, Pain, Neoplasm Progression, Blood Calcium Increased, Injection Site Swelling, Stasis Dermatitis, Constipation, Erythema, Malaise, Injection Site Erythema, Injection Site Induration, Oedema Peripheral, Abdominal Distension, Injection Site Mass, Injection Site Pain, Skin Plaque, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Joint Swelling, Alopecia
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin
Dosage: 1.5 ml, tid
Other drugs received by patient: Fragmin
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-05-14
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Abdominal Distension, Dizziness, Back Pain, Blood Pressure Increased, Humerus Fracture, Vomiting, Nausea, Pain in Extremity, Flushing, Diarrhoea, Arthralgia, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, every three weeks
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-05-09
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Weight Decreased, Confusional State, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Hot Flush, Malaise, Injection Site Erythema, Fatigue, Oedema Peripheral, Abdominal Distension, Dizziness, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-27
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Injection Site Haematoma, Pain, Blood Calcium Increased, Neoplasm Progression, Injection Site Swelling, Constipation, Erythema, Malaise, Injection Site Erythema, Injection Site Induration, Abdominal Distension, Injection Site Mass, Injection Site Pain, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Alopecia
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Sandostatin
Dosage: 1.5 ml, tid
Other drugs received by patient: Fragmin
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-04-20
Patient: female
Reactions: Abdominal Pain, Metastases To Liver, Pain, Neoplasm Progression, Blood Calcium Increased, Injection Site Swelling, Constipation, Erythema, Injection Site Erythema, Malaise, Injection Site Induration, Abdominal Distension, Injection Site Mass, Injection Site Pain, Blood Parathyroid Hormone Increased, Flushing, Neoplasm Malignant, Alopecia
Drug(s) suspected as cause:
Sandostatin
Dosage: 1.5 ml, tid
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-04-13
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Incorrect Route of Drug Administration, Weight Decreased, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Erythema, Hot Flush, Malaise, Fatigue, Oedema Peripheral, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Vertigo
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, qmo
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-06
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Hot Flush, Fatigue, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Gastrointestinal Neoplasm, Dysphonia, Neoplasm Malignant, Arthralgia, Diarrhoea, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-29
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Diarrhoea, Gastrointestinal Neoplasm, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-03-29
Patient: female
Reactions: Abdominal Pain, Injection Site Mass, Metastases To Liver, Pain, Neoplasm Progression, Blood Calcium Increased, Constipation, Erythema, Blood Parathyroid Hormone Increased, Flushing, Malaise, Neoplasm Malignant, Alopecia, Abdominal Distension
Drug(s) suspected as cause:
Sandostatin
Dosage: 1.5 ml, tid
Sandostatin
Dosage: 1 ml, tid
Indication: Neuroendocrine Tumour
Start date: 2010-04-01
Sandostatin LAR
Dosage: 40 mg, every four weeks
Indication: Neuroendocrine Tumour
Start date: 2010-12-20
Sandostatin LAR
Dosage: 60 mg, every 4 weeks
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-03-16
Patient: male
Reactions: Abdominal Pain, Pruritus, Metastases To Liver, Faecal Volume Increased, Hot Flush, Fatigue, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Neoplasm Malignant, Diarrhoea, Arthralgia, Dysphonia, Gastrointestinal Neoplasm, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Other drugs received by patient: Morphine
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-29
Patient: male, weighing 81.0 kg (178.2 pounds)
Reactions: Flushing, Respiratory Distress
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg
Indication: Pancreatic Neuroendocrine Tumour
Start date: 2010-06-20
Sandostatin
Dosage: 600 ug, unk
Indication: Pancreatic Neuroendocrine Tumour
Start date: 2010-11-29
End date: 2012-02-08
Other drugs received by patient: Olmesartan Medoxomil; Berotec; Nifehexal; Allopurinol; Spiriva; Cyclocaps
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Germany on 2012-02-23
Patient: male
Reactions: Flushing, Respiratory Distress
Drug(s) suspected as cause:
Sandostatin LAR
Dosage: 30 mg
Indication: Pancreatic Neuroendocrine Tumour
Start date: 2012-02-09
Sandostatin
Indication: Pancreatic Neuroendocrine Tumour
Start date: 2010-06-20
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-02-22
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Weight Decreased, Incorrect Route of Drug Administration, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Fatigue, Hot Flush, Injection Site Erythema, Malaise, Oedema Peripheral, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Vertigo
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Possible Sandostatin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-02-07
Patient: female
Reactions: Flushing, Drug Ineffective, Injection Site Pain, Neoplasm Progression, Metastases To Lung
Drug(s) suspected as cause:
Sandostatin
Dosage: 200 mg
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, unk
Sandostatin LAR
Dosage: unk
Other drugs received by patient: Simvastatin; Amlodipine; Topiramate; Lisinopril; Soma; Hydrocodin; Potassium; Oxycodone HCL; Levothyroxine Sodium; Lasix; Lopressor; Glipizide; Neurontin; Elidel
Page 1 Next >>
|
